Savvy Updates, 5/27/25:  Sequel/Twiist & Abbott’s Future Dual Glucose/Ketone Sensor, Spleen-based Islet Transplants Without Full Immunosuppression, Medtronic Spins Off Diabetes Business, Kakao Healthcare AI-Powered CGM for Japanese Markets, Elvinix (formerly Levicure) Functional Cure in “Stealth Mode”, Tandem Diabetes Pays Roche $36M in Patent Infringement, FDA Removes Hold on Cadisegliatin (vTv Technologies), FDA OKs Susvimo (Roche) for Diabetic Retinopathy, May is Mental Health Awareness Month & National Diabetes Month

Savvy Updates, 5/27/25: Sequel/Twiist & Abbott’s Future Dual Glucose/Ketone Sensor, Spleen-based Islet Transplants Without Full Immunosuppression, Medtronic Spins Off Diabetes Business, Kakao Healthcare AI-Powered CGM for Japanese Markets, Elvinix (formerly Levicure) Functional Cure in “Stealth Mode”, Tandem Diabetes Pays Roche $36M in Patent Infringement, FDA Removes Hold on Cadisegliatin (vTv Technologies), FDA OKs Susvimo (Roche) for Diabetic Retinopathy, May is Mental Health Awareness Month & National Diabetes Month

In this week’s issue of The Savvy Diabetic:  Sequel/Twiist & Abbott’s Future Dual Glucose/Ketone Sensor Spleen-based islet transplantation restores glycemic control in T1D without full immunosuppression Medtronic Spins Off Diabetes Business Kakao...
Skip to content